What is the effect of venetoclax/venetoclax plus azacitidine treatment?

Venetoclax/The effect of Venetoclax combined with Azacitidine in the treatment of acute myeloid leukemia (AML) has been a research hotspot that has attracted much attention in recent years. This combination treatment combines the different mechanisms of action of the two drugs in the hope of achieving better therapeutic effects.

Veneclase is a selective small moleculeBCL2 inhibitor. It inhibits the function of BCL2 protein and induces apoptosis of malignant cells, thus playing an important role in the treatment of AML. Azacitidine is a nucleoside metabolism inhibitor that can interfere with DNA synthesis and cell proliferation of tumor cells. The combined use of these two drugs can exert a synergistic effect and improve the therapeutic effect.

Multiple clinical trials have shown that the efficacy of venetoclax combined with azacitidine in the treatment of AML patients is encouraging. Compared with monotherapy, combination therapy can significantly extend the overall survival of patients and reduce the risk of death. At the same time, the complete remission rate of combination therapy is also higher, and the duration of complete remission is also longer. This means more patients can achieve long-term disease control and improved quality of life with this treatment option.

In addition to the evaluation of efficacy, this combination treatment regimen also showed good safety characteristics. Although both venetoclax and azacitidine have certain side effects, their combined use did not significantly increase the incidence of adverse reactions. Most patients are able to tolerate this treatment regimen and maintain a good quality of life during treatment.

Of course, the effectiveness of treatment options will also be affected by factors such as individual patient differences, disease stage, and complications. Therefore, in practical applications, doctors need to formulate personalized treatment plans based on the patient's specific conditions, closely monitor changes in the patient's condition, and adjust the treatment plan in a timely manner.